Home/Filings/4/0001225208-21-004301
4//SEC Filing

Carapezzi William R JR 4

Accession 0001225208-21-004301

CIK 0000078003other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:35 PM ET

Size

11.4 KB

Accession

0001225208-21-004301

Insider Transaction Report

Form 4
Period: 2021-02-27
Carapezzi William R JR
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2021-02-27$22.35/sh+21,570$482,09072,522 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2021-02-2721,5700 total
    Exercise: $22.35From: 2021-02-27Exp: 2021-02-27Common Stock (21,570 underlying)
  • Tax Payment

    Common Stock

    2021-02-27$33.49/sh2,985$99,96869,537 total
  • Tax Payment

    Common Stock

    2021-02-27$34.64/sh13,676$473,73755,861 total
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    2,820
Footnotes (5)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]Price is the closing price of Pfizer common stock on February 26, 2021.
  • [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001295078

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:35 PM ET
Size
11.4 KB